Hemophilia prophylaxis with factor VIII concentrate. - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hemophilia prophylaxis with factor VIII concentrate. - Suppr | 超能文献

Hemophilia prophylaxis with factor VIII concentrate.

作者信息

Kasper C K, Dietrich S L, Rapaport S I

出版信息

Arch Intern Med. 1970 Jun;125(6):1004-9.

Abstract

摘要

相似文献

1

Hemophilia prophylaxis with factor VIII concentrate.

Arch Intern Med. 1970 Jun;125(6):1004-9.

2

Calculating the dose of factor VIII in the management of haemophilia.

Br J Haematol. 1981 Jun;48(2):351-4.

3

Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.

N Engl J Med. 1974 Nov 14;291(20):1087.

4

[Treatment of hemophilia A with actor VIII concentrate in urological operations and injuries of the urinary tract].

MMW Munch Med Wochenschr. 1975 Mar 7;117(10):401-4.

5

[Hemostatic management in hemophilia A. Usefulness of APTT and TEG as a method for monitoring Factor VIII concentrates].

Shoni Shikagaku Zasshi. 1985;23(3):760-8.

6

[Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].

Acta Haematol Pol. 1994;25(4):349-54.

7

Factor VIII half-life and clinical phenotype of severe hemophilia A.重度甲型血友病的凝血因子 VIII 半衰期及临床表型

Haematologica. 2005 Apr;90(4):494-8.

8

Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).

Blood Coagul Fibrinolysis. 1996 Mar;7 Suppl 1:S3-6.

9

[The problem of factor VIII inhibitors in patients with congenital coagulopathies].

Z Gesamte Inn Med. 1983 Jan 15;38(2):47-50.

10

[Effect of a single administration of cryoprotein and plasma on factor VIII in hemophilia A].

Vnitr Lek. 1980 Nov;26(11):1101-6.

引用本文的文献

1

Personalized Prophylaxis with myPKFiT: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients.基于 myPKFiT 的个体化预防治疗：血友病 A 患者真实世界的成本效果分析。

Medicina (Kaunas). 2023 Dec 24;60(1):34. doi: 10.3390/medicina60010034.

2

Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China.中国重度 A 型血友病成人患者药物代谢动力学指导预防与标准预防的成本效果分析。

Adv Ther. 2022 Aug;39(8):3777-3788. doi: 10.1007/s12325-022-02220-3. Epub 2022 Jun 30.

3

Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.

推进甲型血友病的个性化治疗：采用无血浆/无白蛋白方法制备的高级别抗血友病因子十年经验

Biologics. 2014 Apr 5;8:115-27. doi: 10.2147/BTT.S53456. eCollection 2014.

4

Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial.比较两种预防方案在重度 A 型血友病成人患者中效果的随机对照试验的理论基础：血友病成人预防试验。

Expert Rev Hematol. 2011 Oct;4(5):495-507. doi: 10.1586/ehm.11.52.

5

Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.抗血友病因子注射剂用于重度甲型血友病出血发作的常规预防及关节损伤风险的综述。

Vasc Health Risk Manag. 2010 Mar 3;6:59-68. doi: 10.2147/vhrm.s5217.

6

Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.凝血因子的药代动力学：对血友病患者的临床意义

Clin Pharmacokinet. 2001;40(11):815-32. doi: 10.2165/00003088-200140110-00003.

7

[Hemolysins and isoagglutinins in substitute preparations containing factor VIII].

Blut. 1972 Jun;24(6):365-71. doi: 10.1007/BF01633549.

8

Current transfusion therapy.当前的输血治疗

Calif Med. 1973 May;118(5):38-55.

9

Haemophilia A home therapy in the United Kingdom 1975-6.1975 - 1976年英国甲型血友病家庭治疗

Br Med J. 1978 Jun 3;1(6125):1447-50. doi: 10.1136/bmj.1.6125.1447.